Insider Transactions and Holdings
-
Entity Type
-
Individual
-
Role
-
10%+ Owner
-
Stock Symbol
-
LTRN on Nasdaq
Aaron G.L. Fletcher - trading volume in the past year for Lantern Pharma Inc.
Holdings reported by Aaron G.L. Fletcher for Lantern Pharma Inc.
| Security |
Num Shares |
Value |
Price $ |
Transaction Date |
Ownership |
Underlying Class |
Underlying Amount |
| Common Stock |
373K |
$1.15M |
$3.09 |
Jun 13, 2025 |
By Bios Fund II QP, LP |
|
|
| Common Stock |
323K |
$999K |
$3.09 |
Jun 13, 2025 |
By Bios Fund I, LP |
|
|
| Common Stock |
189K |
$584K |
$3.09 |
Jun 13, 2025 |
By Bios Fund I QP, LP |
|
|
| Common Stock |
114K |
$353K |
$3.09 |
Jun 13, 2025 |
by Bios Fund II, LP |
|
|
| Common Stock |
50K |
$154K |
$3.09 |
Jun 13, 2025 |
By Bios Fund II NT, LP |
|
|
| Common Stock |
26.1K |
$101K |
$3.86 |
Jun 13, 2025 |
By BP Directors, LP |
|
|
Transactions reported by Aaron G.L. Fletcher for Lantern Pharma Inc.
| Sym |
Class |
Transaction |
% |
Value $ |
* Price $ |
Shares |
Shares After |
Date |
Ownership |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.